Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma
NCT03271632
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL:
CAR T cells
Sponsor
Shenzhen Geno-Immune Medical Institute